Stratipath
PrivateLast Round
Seed
Jul 26, 2021
Total Funding Raised
$2.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stratipath is a healthtech company that develops AI-based precision diagnostic software for cancer treatment decision support.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stratipath Comparables
Compare Stratipath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spotlight Medical | 88% | |
| Aiosyn | 88% | |
| Primaa | 87% | |
Stratipath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 26, 2021 | ||||
| Grant | Jan 1, 2020 |
Key People
Founding team and executive leadership
Stratipath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vinnova | Grant |
| Nascent Invest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 162% MoM.
- Apr 22, 2026
Monthly visitors grew 297% MoM, reaching 2K.
Stratipath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stratipath's valuation, stock price, and market status.